Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

4058 results

Sort By:

Quantitative Imaging Biomarker Prospective Validation of Dynamic Contrast-enhanced MRI as a Metric of Orodental Injury After Radiotherapy (QI-ProVE-MRI)

Study ID: NCT06586892
Start Date: 2025-10-31
End Date: 2032-12-30
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

300

Intervention / Treatment

Radiotherapy followed by chemotherapy

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Metacognitive Therapy vs Unified Protocol for Patients With Comorbid Anxiety Disorders

Study ID: NCT06971692
Start Date: 2025-08
End Date: 2028-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

114

Intervention / Treatment

Metacognitive therapy (MCT)

Unified protocol (UP)

Sponsor

Karolinska Institutet

Source: clinicaltrials.gov

Share:
Add to list

Phase I Trial of rhIL-15 Plus Dinutuximab Plus Irinotecan/Temozolomide for Children and Young Adults With Relapsed/Refractory Neuroblastoma

Study ID: NCT06995872
Start Date: 2025-07-22
End Date: 2029-06-01
Study Type

Interventional

Study Phase

Phase1

No. of Participants

34

Intervention / Treatment

Dheel-15

Dinituximab

Temozolomide

Irinotecan Hydrochloride

Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list

Improving Heart Health in Individuals With SCI Using Home-Based Virtual Gaming

Study ID: NCT06690372
Start Date: 2025-08-01
End Date: 2027-08-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

16

Intervention / Treatment

virtual reality exercise

Sponsor

Drexel University

Source: clinicaltrials.gov

Share:
Add to list

Lenvatinib and Pembrolizumab to Treat Patients With Anal or Rectum Cancer That Has Gotten Worse After Initial Treatment

Study ID: NCT06669572
Start Date: 2026-01-13
End Date: 2029-03-26
Study Type

Interventional

Study Phase

Phase2

No. of Participants

35

Intervention / Treatment

Pembrolizumab

Lenvew

Sponsor

University of Chicago

Source: clinicaltrials.gov

Share:
Add to list

Bedside Ultrasound to Monitor Lung Function and Blood Flow in Newborns Treated With Surfactant

Study ID: NCT07070167
Start Date: 2025-08-30
End Date: 2026-12-30
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

200

Intervention / Treatment

Intratracheal administration of surfactant

Sponsor

Asked Poland sp. Z O.O.

Source: clinicaltrials.gov

Share:
Add to list

A Study of AK146D1 for Injection in Advanced Solid Tumors

Study ID: NCT07067567
Start Date: 2025-07-30
End Date: 2027-05-05
Study Type

Interventional

Study Phase

Phase1

No. of Participants

200

Intervention / Treatment

AK146D1 for injection

Sponsor

Akeso

Source: clinicaltrials.gov

Share:
Add to list

Co-Creating Active Middle School Communities to Increase Student Physical Activity

Study ID: NCT06970067
Start Date: 2026-01-05
End Date: 2028-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

450

Intervention / Treatment

Active Middle School Communities

Sponsor

Deanna Hoelscher

Source: clinicaltrials.gov

Share:
Add to list

A Study of Inhaled Cannabidiol in Healthy Occasional Cannabis Users

Study ID: NCT05320367
Start Date: 2025-09
End Date: 2026-12
Study Type

Interventional

Study Phase

Phase2

No. of Participants

80

Intervention / Treatment

Cannabis, placebo

Sponsor

University of Montreal Hospital Center (CHUM)

Source: clinicaltrials.gov

Share:
Add to list

Feasibility and Acceptability of the Technology Based Enhanced Gender Support Platform Implementation With Parents

Study ID: NCT07022392
Start Date: 2025-10-01
End Date: 2026-03-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

36

Intervention / Treatment

Technology-enhanced gender support platform

Sponsor

Seattle Children's Hospital

Source: clinicaltrials.gov

Share:
Add to list